Jennifer Pietenpol
-
Initiative set to sharpen VUMC’s strategic focus
With the transition of Vanderbilt University Medical Center (VUMC) into a new financial and legal entity now complete, Medical Center leaders view this period as an opportunity to sharpen the organization’s strategic focus. Read MoreJul 14, 2016
-
13 cross-college collaborative projects win TIPs funding
Thirteen interdisciplinary projects, ranging from cellular processes and smart cities to global health care issues, have been selected as the 2016 awardees of the Trans-Institutional Program (TIPs) initiative. Read MoreJun 2, 2016
-
Precision medicine already changing cancer treatment strategies
The ability to test patients’ cancers for individual differences, mainly at the genetic level, and to make treatment decisions based on those differences is the hallmark of precision medicine, and Vanderbilt University Medical Center (VUMC) is among the leaders of this new approach to diagnosis and treatment. Read MoreMay 26, 2016
-
Public invited to learn about VICC precision cancer medicine
Leading cancer investigators from Vanderbilt-Ingram Cancer Center will unveil the latest in cancer research during a community event May 10. Read MoreApr 27, 2016
-
Pietenpol named Executive Vice President for Research
Jennifer Pietenpol, Ph.D., director of the Vanderbilt-Ingram Cancer Center, B.F. Byrd Jr. Professor of Molecular Oncology and Professor of Biochemistry, Cancer Biology and Otolaryngology, has been named Executive Vice President for Research at Vanderbilt University Medical Center (VUMC). Her appointment is effective May 1. Read MoreApr 14, 2016
-
Pietenpol named to NCI Blue Ribbon Panel
Jennifer Pietenpol, Ph.D., B.F. Byrd Jr. Professor of Oncology and director of Vanderbilt-Ingram Cancer Center (VICC), has been selected to serve on a Blue Ribbon Panel that will inform the scientific direction and goals at the National Cancer Institute (NCI) for Vice President Joe Biden’s National Cancer Moonshot Initiative. Read MoreApr 7, 2016
-
New role identified for p73 gene
The p73 gene is required for the generation of cilia – hair-like projections on cells – findings that could have implications for the study of lung diseases and sterility. Read MoreApr 1, 2016
-
T.J. Martell Foundation lauds Pietenpol’s research
Jennifer Pietenpol, Ph.D., B.F. Byrd Jr. Professor of Oncology and director of Vanderbilt-Ingram Cancer Center (VICC), was honored with the Medical Research Advancement Award during the 8th Annual T.J. Martell Foundation Nashville Honors Gala held recently at the Omni Nashville Hotel. Read MoreMar 17, 2016
-
Komen, VICC partnership bolsters breast cancer research
For more than twenty years, Vanderbilt-Ingram Cancer Center’s (VICC) primary source of outside funding has been provided by the National Institutes of Health. But in breast cancer, Susan G. Komen, a nonprofit dedicated to breast cancer research and community services, has been a significant sponsor of research and patient care support. Read MoreOct 8, 2015
-
VICC investigators land Komen breast cancer grants
Two Vanderbilt-Ingram Cancer Center (VICC) investigators — Jennifer Pietenpol, Ph.D., B.F. Byrd Jr. Professor of Oncology and director of VICC, and Valerie Jansen, M.D., Ph.D., medical oncology fellow — have received new cancer research grants awarded by Susan G. Komen, the world’s largest nonprofit funder of breast cancer research. Read MoreOct 1, 2015
-
Strong scores put VICC among top NCI centers
Vanderbilt-Ingram Cancer Center (VICC) has been recognized for the impact of its research programs and excellence in patient care by a panel of National Cancer Institute (NCI) reviewers, receiving an overall “exceptional” score as part of the renewal of the Cancer Center Support Grant (CCSG). Read MoreSep 17, 2015
-
VICC investigators earn breast cancer grants
The grants, which total $830,000, are part of the non-profit organization’s commitment to young scientists, as well as established investigators who are searching for more effective breast cancer therapies. Read MoreOct 23, 2014
-
Pietenpol named to IOM Cancer Policy Forum
Jennifer Pietenpol, Ph.D., B.F. Byrd Jr. Professor of Oncology and director of Vanderbilt-Ingram Cancer Center, has been named an at-large member of the National Cancer Policy Forum, an advisory group of the Institute of Medicine (IOM) of the National Academies. Read MoreJul 10, 2014
-
VICC receives $100,000 ovarian cancer research grant
The Kay Yow Cancer Fund, in partnership with the Women’s Basketball Coaches Association and The V Foundation for Cancer Research, has awarded a $100,000 ovarian cancer research grant to the Vanderbilt-Ingram Cancer Center. Read MoreJan 21, 2014
-
VICC debuts new Center for Cancer Targeted Therapies
Vanderbilt-Ingram Cancer Center leaders formally dedicated the space for the new Center for Cancer Targeted Therapies (CCTT), located in the Infusion Center on the second floor of The Vanderbilt Clinic, at a special ribbon-cutting held during last week’s fall meeting of the Cancer Center’s Board of Overseers. Read MoreOct 31, 2013
-
Komen grants bolster breast cancer research
Vanderbilt-Ingram Cancer Center investigators are receiving $1 million in breast cancer research grant funds from Susan G. Komen, the largest nonprofit foundation supporting breast cancer research. Read MoreAug 15, 2013
-
West Tennessee Healthcare and Vanderbilt University Medical Center announce academic affiliation agreement
Kirkland Cancer Center Leaders of West Tennessee Healthcare (WTH) and Vanderbilt University Medical Center today announced an academic affiliation agreement which further establishes a collaborative relationship between the two institutions, now for the creation of new cancer programs in West Tennessee. The new agreement creates a… Read MoreMay 21, 2013
-
Record number elected AAAS fellows
Seventeen members of Vanderbilt University’s faculty have been elected fellows of the American Association for the Advancement of Science (AAAS) this year. Read MoreNov 29, 2012
-
Cancer research and education agreement announced between Baptist Memorial Health Care and Vanderbilt University
Executives with Baptist Memorial Health Care Corporation in Memphis, Tenn., and Vanderbilt University Medical Center today announced an academic affiliation agreement — paving the way for new clinical research and academic education opportunities that are designed to enhance cancer programs. The new affiliation establishes a framework… Read MoreOct 29, 2012
-
Vanderbilt cancer investigators win two national GE cancer research grants
Vanderbilt-Ingram Cancer Center investigators have won two of the five global innovation grants awarded by the “GE Healthymagination Cancer Challenge.” Read MoreMar 28, 2012